>  
Report Detail

Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 32

Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Hypertropic Cardiomyopathy – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypertropic Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertropic Cardiomyopathy. Hypertropic Cardiomyopathy – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Hypertropic Cardiomyopathy.
- A review of the Hypertropic Cardiomyopathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hypertropic Cardiomyopathy pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Hypertropic Cardiomyopathy.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Hypertropic Cardiomyopathy pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hypertropic Cardiomyopathy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Hypertropic Cardiomyopathy 7
Hypertropic Cardiomyopathy Therapeutics under Development by Companies 9
Hypertropic Cardiomyopathy Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Hypertropic Cardiomyopathy Therapeutics - Products under Development by Companies 13
Hypertropic Cardiomyopathy Therapeutics - Products under Investigation by Universities/Institutes 14
Companies Involved in Hypertropic Cardiomyopathy Therapeutics Development 15
Novartis AG 15
Hypertropic Cardiomyopathy - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
ARRY-162 - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
perhexiline - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
diltiazem hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
atorvastatin calcium - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
losartan potassium - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
losartan potassium - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables
Number of Products Under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Products under Development by Companies, H2 2012 13
Products under Investigation by Universities/Institutes, H2 2012 14
Novartis AG, H2 2012 15
Assessment by Monotherapy Products, H2 2012 16
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Stage and Molecule Type, H2 2012 20
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30

List of Figures
Number of Products under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Assessment by Monotherapy Products, H2 2012 16
Assessment by Route of Administration, H2 2012 17
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Molecule Type, H2 2012 19
Assessment by Stage and Molecule Type, H2 2012 20
  • Understand the Basics before Entering the World of IPTV
    IPTV or internet protocol television is an innovative technology, which has changed the appearance of the television programming across the globe. Internet protocol television provides television programming through broadband connection, which works according to the internet protocols. Television viewers who want to enjoy this viewing experience need to subscribe to the IPTV service and buy [...]
  • Introduction to Digital Radiography Imaging
    X-ray imaging is as a diagnostic method for quite some time now. Digital radiography is one of the common x-ray imaging techniques, which is popular in the medical discipline. In this technology, digital x-ray sensors are used that help capturing images onto the image capture devices. These devices then convert these images into digital image [...]
  • Computed Tomography (CT) Scan Technology Important For Therapeutic & Diagnostic
    Various medical disciplines use several types of tests and scans for therapeutic and diagnostic purposes. Computed tomography is one of the common medical imaging procedures. Also known as CT scan, this technology uses computed X-rays to produce tomographic images of various body parts. This nondestructive process helps visualizing various interior features of the body, within [...]
  • An Overview of Interactive Television with Benefits and Features
    Media convergence technology has reached to new heights. Interactive television or ITV is one of the popular forms of media convergence that adds data services to the conventional television sets. In simple language, interactive TV is the television that the users can interact with and change its appearance as per their own preferences. This feature [...]
  • What is Home Healthcare and How to Find Suitable Services ?
    Old age soon takes its toll on the abilities of taking care of your personal and healthcare needs. The number of senior citizens requiring assistance for healthcare is significantly rising. Not all of them are able to seek help from their loved ones. Elderly, who are not able to receive personal attention from their relatives [...]
  • Vaccines – African Markets Package
    "......es Market for vaccines by product type Forecasts and future outlook of the market Macroeconomic indicators These Market Studies Answer To Questions Such As: What is the size of the vaccine markets in different African countries? How ar......"
  • Vaccines – Asian Markets Package
    "...... Market for vaccines by product type Forecasts and future outlook of the market Macroeconomic indicators These Market Studies Answer To Questions Such As: What is the size of the vaccine markets in different Asian countries? How are the ......"
  • Vaccines – Eastern European Markets Package
    "......n European countries Market for vaccines by product type Forecasts and future outlook of the market Macroeconomic indicators These Market Studies Answer To Questions Such As: What is the size of the vaccine markets in different Eastern E......"
  • Vaccines – Western European Markets Package
    "......n European countries Market for vaccines by product type Forecasts and future outlook of the market Macroeconomic indicators These Market Studies Answer To Questions Such As: What is the size of the vaccine markets in different Western E......"
  • Vaccines – European Markets Package
    "......ries Market for vaccines by product type Forecasts and future outlook of the market Macroeconomic indicators These Market Studies Answer To Questions Such As: What is the size of the vaccine markets in different European countries? How......"